Dual Antiplatelet Therapy
Alternative Names: DAPT
Dual antiplatelet therapy (usually aspirin plus clopidogrel) is used after a minor ischemic stroke or high-risk TIA to reduce the risk of early recurrence. It is most effective when started promptly and continued for 21–90 days, after which patients transition back to single antiplatelet therapy. Studies have shown that short-term DAPT provides better protection against recurrent stroke than aspirin alone. However, prolonged use increases bleeding risk, so therapy duration is limited. DAPT is now a well-established part of secondary prevention protocols in carefully selected patients.
Treatment Type: Prescription Medication
Treatment Class: N/A
Treatment Modality: N/A
Review Summary
Based on the review by Dr. Curbside, Dual Antiplatelet Therapy (DAPT) appears to be an effective treatment for reducing early recurrence risk in minor ischemic stroke or high-risk transient ischemic attack (TIA). However, the treatment requires careful management due to the balance between potential benefits and bleeding risks, and is typically recommended for a short-term course under neurology guidance.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
AI Summary of User Experiences
Not medical advice.
Based on the review by Dr. Curbside, Dual Antiplatelet Therapy (DAPT) appears to be an effective treatment for reducing early recurrence risk in minor ischemic stroke or high-risk transient ischemic attack (TIA). However, the treatment requires careful management due to the balance between potential benefits and bleeding risks, and is typically recommended for a short-term course under neurology guidance.
No reviews yet.
Be the first to share your experience with this treatment. Your insights help others make informed decisions about their care.
Reviews
Filter by reviewer type Pro